News

Pluristem has submitted a scientific package to the PEI. The package contains the results of a proof of concept study and preclinical study synopses utilizing PLX-PAD to support

The patent application was submitted under the patent cooperation treaty with 33 claims covering the device, related systems and methods of use. All 33 claims were allowed by

Niox Mino provides accurate, reproducible and immediate measurement of fractional exhaled nitric oxide, a validated method for assessing asthma-related airway inflammation. Niox Mino is said to be the

The orphan drug designation will entitle Mpex to a seven-year period of exclusive marketing rights for MP-376 for the orphan indication following the date of the drug’s marketing

The companies will evaluate and execute product development programs directed at immune stimulation and disease prevention in a variety of animal species. In addition, the agreement anticipates that

Under the terms of the partnership, Millipore will gain exclusive rights to distribute Guava’s non-clinical instrumentation within defined fields in North America, Europe and other countries in Asia.

Dainippon Sumitomo Pharma has a large product portfolio in the CNS area and has adopted a multifaceted research approach to target better treatments for psychiatric conditions, including schizophrenia,

The Equate study has enrolled over 700 patients with body mass index ranging from 30 to 45 in 35 clinical sites. Patients in the Equate study will undergo

The collaboration integrates the NCCN Clinical Practice Guidelines in Oncology, Drugs and Biologics Compendium and Standard Chemotherapy Order Templates into the Cerner Millennium healthcare computing platform. NCCN’s Guidelines